KTOV News and Press, Kitov Pharma Ltd. From 08/12/20

TEL AVIV, Israel, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, announced today that the Company will change the ratio of its ...

TEL AVIV, Israel, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today provided a corporate update and announced financial resu...

Will These Be On Your List Of Penny Stocks To Buy Or Sell This Week? Are penny stocks “back”? Some have said that small-cap and micro-cap stocks were stalling. While I don’t agree with that, I can see where the idea might stem from. If you’re only looking at bro...

Will These Penny Stocks Under $1.50 Stay There Before The End Of July? When you talk about the definition of penny stocks , it’s a pretty broad definition. According to the Securities & Exchange Committee, the definition of penny stocks are equities trading below $5 per share. ...

Kitov Pharma ( KTOV -6.8% ) initiates Phase 1/2 trial of NT219 as monotherapy for advanced solid tumors, as well as in combination with cetuximab, a monoclonal antibody that blocks epithelial growth factor receptor, as a second-line or third-line treatment of recurren...

Company Evaluating NT219 as Monotherapy Treatment of Advanced Solid Tumors and in Combination with Cetuximab for the Treatment of Recurrent and/or Metastatic Solid Tumors and Head and Neck Cancer Preliminary Data from the First Part of this Study Anticipated to be Available ...

Are These Penny Stocks To Buy According To You? Penny stocks are volatile on their own. But when you mix them with certain sectors, that can become a bit more explosive. Specifically, biotechnology penny stocks are some of the most active among stocks under $5. The reason why has everythin...

The European Patent Office intends to grant a new patent to Kitov Pharma (NASDAQ: KTOV ) for application entitled “Humanized antibodies against CEACAM1.” More news on: Kitov Pharma Ltd, Healthcare stocks news, Stocks on the move, Read more ...

Patent coverage for CM24 now extends to the U.S. and the EU TEL AVIV, Israel, July 08, 2020 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resi...

Kitov Pharma Ltd. ( KTOV ) has recently become one of the most commented stocks on Twitter. The company is a clinical-stage pharmaceutical company having ties with Merck (MRK) and venture capital firms, like Arkin Holdings, Orbimed, and Pontifax. I cannot really explain why the market, at th...